ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer
Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near London, England, GBR:

Surveillance of Pancreatic Health After Diabetes Diagnosis (SAFE-D)

The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer...

Enrolling
Pancreatic Cancer, Adult
Diabetes Mellitus
Device: Avantect Pancreatic Cancer Test
University Hospital Southampton NHS Foundation Trust

London, United Kingdom and 13 other locations

This is an open-label, multi-centre, randomised, stratified, phase IIb clinical trial of ATRA administered in combination with gemcitabine and nab-pa...

Active, not recruiting
Pancreatic Cancer
Drug: nab-paclitaxel
Drug: Gemcitabine

Phase 2

Queen Mary University of London

London, United Kingdom

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: AMG 193
Drug: Gemcitabine

Phase 1

Amgen
Amgen

London, United Kingdom and 76 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

London, City Of London, United Kingdom and 91 other locations

is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of Locally Advanced Pancreatic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: OncoSil™
Drug: FOLFIRINOX chemotherapy

Phase 2

OncoSil Medical

London, United Kingdom and 16 other locations

This is a study designed to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of WEF-001 as monotherapy in patients with Adv...

Enrolling
Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer
Advanced Solid Tumors
Drug: WEF-001

Phase 1, Phase 2

Auricula Biosciences Inc.

Headington, Oxford, United Kingdom and 2 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Active, not recruiting
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Sutton, United Kingdom and 67 other locations

to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...

Active, not recruiting
Pancreatic Cancer Harboring NRG1 Fusion
NSCLC Harboring NRG1 Fusion
Drug: zenocutuzumab (MCLA-128)

Phase 2

Partner Therapeutics

London, United Kingdom and 63 other locations

This is a multi-centre, investigator-initiated, dose escalation, Phase I trial of the combination of the FAK inhibitor, Defactinib (VS-6063), and the...

Active, not recruiting
Low Grade Serous Ovarian Cancer
Pancreatic Cancer
Drug: VS-6766
Drug: Defactinib

Phase 1

Institute of Cancer Research, United Kingdom

London, United Kingdom and 4 other locations

This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...

Active, not recruiting
Exocrine Pancreatic Cancer
Colorectal Neoplasms
Drug: cisplatin
Drug: carboplatin

Phase 2

Seagen, a wholly owned subsidiary of Pfizer

London, London, CITY of, United Kingdom and 149 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems